# Triton Therapeutics, Inc. — Form D

Triton Therapeutics, Inc. of STAMFORD, CT, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-23. The offering totals $36.4M, of which $36.4M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2025-10-23
- Form: D
- Accession: 0002088152-25-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $36.4M
- Amount sold: $36.4M
- Investors: 4
- Date of first sale: 2025-10-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-561892

## Issuer

- Name: Triton Therapeutics, Inc.
- CIK: 0002088152
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 700 FAIRFIELD AVENUE, SUITE 1, STAMFORD, CT, 06902
- Phone: 203-482-3123

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Paul Fonteyne | Director | New Haven, CT |
| Elena Grigoryeva | Director | Princeton, NJ |
| Annie Mitsak | Director | Boston, MA |
| Timothy Shannon | Director | Stamford, CT |
| Paul Fonteyne | Executive Officer | New Haven, CT |

## More

- [CIK 2088152 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2088152&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002088152-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.